Work

Phase 1, open-label, dose-escalation, and expansion study of ABT-700, an anti-C-met antibody, in patients (pts) with advanced solid tumors.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.2507

Authors: John H. Strickler, Patricia LoRusso, Chia-Jui Yen, Chia-Chi Lin, Yoon-Koo Kang, Patrick Kaminker, Peter Ansell, Anahita Bhathena, Shekman Wong, Matthew W. Dudley, Louie Naumovski, Ramesh K. Ramanathan

Institutions: Duke Medical Center, Wayne State University, The Barbara Ann Karmanos Cancer Institute, National Cheng Kung University Hospital, National Taiwan University Hospital, Asan Medical Center, AbbVie (United States), AbbVie Biotherapeutics (United States), Translational Genomics Research Institute

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2508093589

Cites:

Cited by: 29

Related to: 10